Engaging Black Men in Colorectal Cancer Screening (SUCCEED)

August 4, 2025 updated by: Virginia Commonwealth University

SUCCEED: Engaging Black Men in Colorectal Cancer Screening (CRC) Screening

To determine the unmet needs, attitudes, barriers and facilitators of African American (AA)/ Black men use of colorectal cancer screening and describe how community leaders such as barbers may act as Community Champions to educate and facilitate screening participation.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Virginia
      • Richmond, Virginia, United States, 23298
        • Virginia Commonwealth University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult men
  • Identify as Black or African American
  • Work or live in Petersburg, VA or surrounding counties
  • Eligible for colorectal cancer (CRC) screening at time of study enrollment

Exclusion Criteria:

  • Inability to speak or read English
  • Currently up-to-date with CRC screening

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tailored Screen to Save (S2S) content
Content to be delivered using a combination of short video and text-based information optimized for delivery via Quick Response (QR) codes for smartphones.
Behavioral: mHealth Application
Self-directed application (app) that is downloaded to the participant's personal device. The app contains five informational videos, that provide an orientation to the content on the app, and discuss what colorectal cancer is, and the type of CRC screening tests that are available as well as a video with a personal history. There is a a National Cancer Institute (NCI) risk calculation tool, and a family history infographic. Once the videos have been viewed participants have the option to indicate if they wish to receive a call from the healthcare clinic to discuss scheduling an appointment for screening.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Colorectal Screening Status
Time Frame: 3 Months
The number of participants that complete screening (any type)
3 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determine Feasibility of Mobile Health (mHealth) Application -Enrollment
Time Frame: Week 1
The number of men that enroll for the intervention (application)
Week 1
Determine the Feasibility of the mHealth Application-Videos
Time Frame: Week 1
The number of participants that view the videos
Week 1
Determine the Feasibility of the mHealth Application- Retention
Time Frame: Baseline (Day 1), Week 2, and Week 12
The number of participants that complete Questionnaires (>65%)
Baseline (Day 1), Week 2, and Week 12
Determine the Feasibility of the mHealth Application- Clinic/ Screening Request
Time Frame: Week 12
The number of participants that respond to the request to contact clinic/ navigation services
Week 12
Determine the Feasibility of the mHealth Application - Sharing Content
Time Frame: Week 12
The number of participants that share content on social network
Week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Virginia Commonwealth University

Collaborators

National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Maria Thomson, Ph.D., Virginia Commonwealt University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 5, 2023

Primary Completion (Actual)

June 25, 2024

Study Completion (Actual)

June 25, 2024

Study Registration Dates

First Submitted

July 27, 2023

First Submitted That Met QC Criteria

August 4, 2023

First Posted (Actual)

August 7, 2023

Study Record Updates

Last Update Posted (Actual)

August 20, 2025

Last Update Submitted That Met QC Criteria

August 4, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MCC-21-18632
  • HM20023619 (Other Identifier: Virginia Commonwealth University)
  • CA264067-01 (Other Grant/Funding Number: NCI)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe